ACE Inhibition in the Management of High Blood Pressure: Pocketbook

Front Cover
Taylor & Francis, Apr 8, 1999 - Medical - 72 pages
ACE inhibitors were specifically designed to block the enzyme that is responsible for converting the inactive peptide angiotensin I to the active and powerful vasoconstrictor angiotensin II. Of all antihypertensive drugs, ACE inhibitors have the least adverse effects and patients feel extremely well on these drugs. They are approved for all degrees of hypertension and are of particular value when congestive heart failure coexists.

What people are saying - Write a review

We haven't found any reviews in the usual places.

Other editions - View all

About the author (1999)

[MD PhD FRCP] - Consultant Physician/Cardiologist, Raigmore Hospital Cardiac Unit

Bibliographic information